With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative
We recently participated at the Spectrum Miami Conference, where we had the opportunity to showcase Micromate™ and connect with leading professionals in interventional radiology and oncology.
Partnership will Expand Shoulder Innovations’ Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC robotics Shoulder Innovations, Inc. (Shoulder Innovations,
Interventional Systems, a pioneer in miniature medical robotics, and Siemens Healthineers, a global leader in medical technology, are proud to announce a co-marketing agreement to
Leveraging Micromate™ robotic technology, the new device’s approval for clinical use marks a new era for robot-assisted spinal surgery in China, driven by a successful
Carlos Tavares, 76, was one of the first patients to benefit from the robotic precision of Micromate™ in Portugal, at the Local Health Unit of Gaia and Espinho (ULS Gaia and Espinho).
For the first time, a leak in the largest lymph vessel in a patient’s body has been treated with a micro-robot-assisted puncture and vascular closure.
Discover how strategic partnerships can bridge the gap of market adoption in the surgical robotics industry.
See how Micromate™’s ability to reach challenging anatomical regions has been helping clinical teams perform successful percutaneous procedures from head to toe.
Micromate™ is now the first needle-based intervention robot available for sale in the United States that is compatible with both fluoroscopy and computed tomography (CT).
Learn how a robotic assistance system like Micromate™ can help you improve your IR/IO percutaneous needle interventions.
Learn how our cost-effectiveness approach to medical robotics makes Micromate™ the most accessible robot for every hospital.
